[Federal Register Volume 64, Number 104 (Tuesday, June 1, 1999)]
[Notices]
[Pages 29328-29329]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-13751]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel Genetics of Drug Abuse Vulnerability.
Date: June 1-2, 1999.
Time: 9:00 AM to 5:00 PM.
Agenda: To review and evaluate grant applications.
Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes
Street, Arlington, VA 22202.
Contact Person: Rita Liu, PHD, Health Scientist Administrator,
Office of Extramural Program Review, National Institute on Drug
Abuse, National Institutes of Health, DHHS, 6001 Executive
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-
2620.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, National Drug Abuse Treatment Clinical Trials
Network.
Date: June 22-23, 1999.
Time: 9:00 AM to 5:00 PM.
Agenda: To review and evaluate grant applications.
Place: Omni Shoreham Hotel, 2500 Calvert Street, NW.,
Washington, DC 20008.
Contact Person: Susan L. Coyle, PHD, Chief, Clinical
Epidemiological and Applied Sciences Review Branch, Office of
Extramural Program Review, National Institute on Drug Abuse,
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel Program Projects Review Committee.
Date: June 29, 1999.
Time: 8:30 AM to 5:00 PM.
Agenda: To review and evaluate grant applications.
Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA
22209.
Contact Person: Rita Liu, PHD, Health Scientist Administrator,
Office of Extramural Program Review, National Institute on Drug
Abuse, National Institutes of Health, DHHS, 6001 Executive
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-
2620.
Name of Committee: National Institute on Drug Abuse Initial
Review Group Treatment Research Subcommittee.
Date: June 29-30, 1999.
Time: 9:00 AM to 5:00 PM.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Kesinee Nimit, MD, Health Scientist
Administrator, Office of Extramural Program Review, National
Institute on Drug Abuse, National Institutes of Health, DHHS, 6001
Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547,
(301) 435-1432.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel Centers Review Committee.
Date: June 30, 1999.
Time: 8:30 AM to 5:00 PM.
Agenda: To review and evaluate grant applications.
Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA
22209.
Contact Person: Rita Liu, PHD, Health Scientist Administrator,
Office of Extramural Program Review, National Institute on Drug
Abuse, National Institutes of Health, DHHS, 6001 Executive
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-
2620.
Name of Committee: National Institute on Drug Abuse Initial
Review Group Training and Career Development Subcommittee.
Date: July 7-9, 1999.
Time: 9:00 AM to 5:00 PM.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda One, Bethesda Metro Center
Bethesda, MD 20814.
Contact Person: Mark Swieter, PHD, Health Scientist
Administrator, Office of Extramural Program Review, National
Institute on Drug Abuse, National Institutes of Health, DHHS, 6001
Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547
(301) 435-1389.
Name of Committee: National Institute on Drug Abuse Initial
Review Group Health Services Research Subcommittee.
[[Page 29329]]
Date: July 14, 1999.
Time: 9:00 AM to 5:00 PM.
Agenda: To review and evaluate grant applications.
Place: Omni Shoreham Hotel, 2500 Calvert Street, NW, Washington,
DC 20008.
Contact Person: Marina L. Volkov, PHD, Special Assistant, Office
of Extramural Program Review, National Institute on Drug Abuse,
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room
3158, MSC 9547, Bethesda, MD 20892-9547 (301) 435-1433.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel Research on Drug Courts.
Date: July 19-20, 1999.
Time: 9:00 AM to 5:00 PM.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Hotel, 5151 Pooks Hill Road, Bethesda,
MD 20814.
Contact Person: Marina L. Volkov, PHD, Special Assistant, Office
of Extramural Program Review, National Institute on Drug Abuse,
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1433.
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse Research Programs, National Institutes of Health,
HHS)
Dated: May 23, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 99-13751 Filed 5-28-99; 8:45 am]
BILLING CODE 4140-01-M
